Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds
NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer
Two-Point Rise In PSA Signals High-Risk Prostate Cancer
High Cervical Cancer Rates Indicate Access Problems
Lifestyle Changes Common After Cancer Diagnosis
Proton Beam Radiation Helps Cancer Patients Retain Vision
Cooperative Group Trials Approved By NCI Are Listed
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









